Skip to main content
. Author manuscript; available in PMC: 2014 Sep 22.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008042. doi: 10.1002/14651858.CD008042.pub2
Summary of results C: any adverse event
Drug Dose (mg) Route Studies Participants Triptan % Placebo % NNH (95% CI)
Zolmitriptan 5 Oral, nasal spray 2 331 27 15 8.4 (4.8 to 31)
Zolmitriptan 10 Oral, nasal spray 2 325 37 15 4.6 (3.2 to 8.0)
Sumatriptan 6 Subcutaneous 2 293 34 19 6.6 (4.0 to 19)
Sumatriptan 12 Subcutaneous 1 190 45 16 Not calculated